AI Is Fueling a New Arms Race in Healthcare: Here’s How We Stop It

Why It Matters

If left unchecked, competing AI systems will delay care and erode payer‑provider relationships, while coordinated AI can streamline authorizations and reduce costs across the industry.

Key Takeaways

• Provider and payer AIs can conflict, delaying care
• CMS rule mandates FHIR APIs by 2027
• Transparency required to avoid black‑box compliance risks
• Interoperable, embedded AI reduces workflow friction
• Health plans must retain policy governance

Pulse Analysis

The surge of artificial‑intelligence tools in health‑care utilization management is reshaping the prior‑authorization process, but not always for the better. Provider‑focused models that automatically approve requests clash with payer‑side algorithms designed to flag cost or fraud, creating a feedback loop that can stall treatment and increase administrative burden. This emerging AI arms race coincides with regulatory momentum: the CMS Interoperability and Prior Authorization Final Rule (CMS‑0057‑F) requires FHIR‑based APIs and real‑time responses by 2027, while the AHIP‑Blue Cross pledge calls for transparent, electronic authorizations. Together, these forces set the stage for a decisive shift in how decisions are made.

To prevent adversarial outcomes, AI must be built for collaboration rather than competition. Transparency is paramount; models should expose the clinical criteria and policy logic that drive each recommendation, allowing clinicians and auditors to trace decisions back to source data. Interoperability must extend beyond data exchange standards to shared governance frameworks that align payer and provider policies within a federated ecosystem. Embedding AI directly into point‑of‑care interfaces—such as EHR screens where clinicians submit and receive authorizations—eliminates the need for separate portals, accelerates turnaround times, and reduces user friction.

Health plans are uniquely positioned to steer this transformation by retaining control over their medical‑policy engines while demanding bi‑directional integration from vendors. Conducting an audit of existing UM technology for auditability, investing in joint decision‑support frameworks, and partnering with platforms that honor FHIR standards will preserve oversight and protect data ownership. As the market rewards organizations that deliver faster, more reliable authorizations, payers that champion transparent, interoperable AI will gain competitive advantage, lower provider abrasion, and reinforce trust across the care continuum. The next wave of utilization management will be defined by fairness and shared accountability, not by the speed of the fastest algorithm.